| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On May 30, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2006N-0362
|
| General and Plastic Surgery Devices; Reclassification of the Absorbable Hemostatic Device
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2006P-0536
|
| Amend 21 C.F.R. 312. promotion and charging for investigational drugs re: pandemic vaccine
|
|
|
|
|
| 2007D-0020
|
| Medical Devices: Class II Special Controls Guidance Document: Oxygen Pressure Regulators and Oxygen Conserving Devices
|
|
|
|
|
| 2007D-0089
|
| Guidance for Industry and Review Staff on Target Product Profile A Strategic Development Process Tool
|
|
|
|
|
| 2007D-0101
|
| Guidance for the Public, FDA Advisory Committee Members, and FDA Staff on Procedures for Determining Conflict of Interest and Eligibility for Participation in FDA Advisory Committees
|
|
|
|
|
| 2007N-0019
|
| Medical Devices; Anesthesiology Devices; Oxygen Pressure Regulators and Oxygen Conserving Devices
|
|
|
|
|
| 2007N-0051
|
| Safety of Fresh Produce; Public Hearings
|
|
|
|
|
| 2007N-0121
|
| Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
|
|
|
|
|
| 2007P-0216
|
| Determine that an additional dosage of Deferoxamine Mesylate for Injection, USP is suitable for an abbreviated new drug application (ANDA)
|
|
| |
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
|
|
|
|
| EC 8254
|
| Mrs. D Chavez
|
| Vol #:
|
| 203
|
|
|
|
|
| EC 8255
|
| Ms. Gail Lange
|
| Vol #:
|
| 203
|
|
|
|
|
| EC 8256
|
| Mrs. Stacey Prince
|
| Vol #:
|
| 203
|
|
|
|
|
| EC 8257
|
| Miss. Abra Snow
|
| Vol #:
|
| 203
|
|
|
|
|
| EC 8258
|
| parent
|
| Vol #:
|
| 203
|
|
|
|
|
| EC 8259
|
| Mrs. Lisa Stern
|
| Vol #:
|
| 203
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| C 18307
|
| K. Lieberman
|
| Vol #:
|
| 198
|
|
|
|
|
| C 18308
|
| D. Cooley
|
| Vol #:
|
| 198
|
|
|
|
|
| 2006N-0362
|
| General and Plastic Surgery Devices; Reclassification of the Absorbable Hemostatic Device
|
|
|
|
|
| C 7
|
| Center for general and Minimally Invasive Surgery
|
| Vol #:
|
| 1
|
|
|
|
|
| C 8
|
| Beth Israel Deaconess Medical Center
|
| Vol #:
|
| 1
|
|
| |
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| C 94
|
| S Loshuertos
|
| Vol #:
|
| 7
|
|
|
|
|
| 2006P-0536
|
| Amend 21 C.F.R. 312. promotion and charging for investigational drugs re: pandemic vaccine
|
|
|
|
|
| LET 1
|
| FDA/CBER to Vaccine Fol All LLC
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0020
|
| Medical Devices: Class II Special Controls Guidance Document: Oxygen Pressure Regulators and Oxygen Conserving Devices
|
|
|
|
|
| C 1
|
| National Institute for Occupational Safety and Health (NIOSH)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0089
|
| Guidance for Industry and Review Staff on Target Product Profile A Strategic Development Process Tool
|
|
| | | | | | | | |
|
| |
|
| C 1
|
| Bristol-Myers Squibb Company
|
| Vol #:
|
| 1
|
|
|
|
|
| C 2
|
| Wyeth Pharmaceuticals Inc
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 1
|
| Johnson and Johnson PRD
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 2
|
| AstraZeneca LP
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 3
|
| Pfizer
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 4
|
| Novartis Pharmaceuticals
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 5
|
| Merck Research Laboratories
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 6
|
| sanofi-aventis
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 7
|
| Amgen
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0101
|
| Guidance for the Public, FDA Advisory Committee Members, and FDA Staff on Procedures for Determining Conflict of Interest and Eligibility for Participation in FDA Advisory Committees
|
|
|
|
|
|
| |
|
|
|
| C 4
|
| American Academy of Orthopaedic Surgeons (AAOS)
|
| Vol #:
|
| 1
|
|
|
|
|
| C 5
|
| University of Memphis
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 47
|
| Animal Health Institute
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 48
|
| Cancer Leadership Council
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 49
|
| BIO
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 50
|
| National Research Center for Women
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 51
|
| Project on Government Oversight
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 52
|
| Dr. Jeff Angel
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 53
|
| Alliance of Specialty Medicine
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 54
|
| Dr. Joshua Jacobs
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0019
|
| Medical Devices; Anesthesiology Devices; Oxygen Pressure Regulators and Oxygen Conserving Devices
|
|
|
|
|
| C 3
|
| National Institute for Occupational Safety and Health (NIOSH)
|
| Vol #:
|
| 1
|
|
|
|
|
| C 4
|
| Compressed Gas Association
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 1
|
| Compressed Gas Association
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0051
|
| Safety of Fresh Produce; Public Hearings
|
|
|
|
|
| TR 2
|
| Transcript April 13, 2007 Hearing
|
| Vol #:
|
| 5
|
|
|
|
|
| 2007N-0121
|
| Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
|
|
|
|
|
| EAPE 234
|
| Gerami-Diznab, Soheila
|
| Vol #:
|
| 7
|
|
|
|
|
| 2007P-0216
|
| Determine that an additional dosage of Deferoxamine Mesylate for Injection, USP is suitable for an abbreviated new drug application (ANDA)
|
|
|
|
|
| ACK 1
|
| FDA/DDM to Ben Venue Laboratories, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| Ben Venue Laboratories, Inc.
|
| Vol #:
|
| 1
|
|
